Previous Article | Next Article ![]()
Journal of Bacteriology, April 2007, p. 3006-3016, Vol. 189, No. 8
0021-9193/07/$08.00+0 doi:10.1128/JB.01544-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, Calgary, Alberta, Canada T2N 4N1
Received 3 October 2006/ Accepted 29 January 2007
|
|
|---|
|
|
|---|
In addition to having biocontrol, bioremediation, and plant growth-enhancing applications (38, 45), BCC species are also opportunistic pathogens of particular importance for people with cystic fibrosis (CF) and chronic granulomatous disease (41). Each BCC species has been isolated from CF patients; however, the species vary in frequency of colonization, transmissibility, and geographic distribution. Burkholderia cenocepacia is the most commonly reported BCC species isolated from CF patients in North America, where 80 percent of BCC isolates recovered from CF patients in Canada and 50 percent of BCC isolates recovered from patients in the United States are B. cenocepacia (35, 56). There is a low incidence of B. vietnamiensis infections in North American CF patients; such infections comprise 1.6 percent of Canadian and 5.1 percent of U.S. CF patient BCC isolates (47, 57). An epidemiological study conducted in Brazil with 11 patients, however, reported equal incidences of B. cenocepacia and B. vietnamiensis isolates from CF patients, illustrating the potential of B. vietnamiensis as a CF pathogen (16). The pathogenic potential of B. vietnamiensis has delayed further research on its biotechnological applications (9).
BCC species utilize N-acyl-homoserine lactone (AHL)-based quorum-sensing systems for the regulation of diverse physiological processes, including those involved in virulence. Quorum sensing is a form of genetic regulation typically mediated by the accumulation of self-produced signal compounds in the environment. AHL-mediated quorum-sensing systems are comprised of a luxI homologue, which encodes an AHL synthase that catalyzes the synthesis of an AHL signal molecule(s), and a luxR homologue that encodes a transcriptional regulator that mediates gene expression in its active, AHL-bound form (22).
The cepIR quorum-sensing system is widely distributed among BCC strains (26, 36). CepI directs the synthesis of N-octanoyl-homoserine lactone (OHL) and N-hexanoyl-homoserine lactone (HHL) (32, 33). In B. cepacia, the cepIR quorum-sensing system is autoregulated in that CepR positively regulates the expression of cepI (2). Transcriptional analysis of a B. cepacia promoter library identified 28 genes that are positively regulated by CepR (2). The B. cepacia cepIR system also negatively regulates the stationary-phase sigma factor rpoS, positively regulates protease production, and contributes to onion maceration by positively regulating polygalacturonase production (1).
In B. cenocepacia, CepR positively regulates cepI expression and negatively controls its own expression (33). The cepIR quorum-sensing system in B. cenocepacia is involved in the regulation of swarming motility, mature biofilm development, chitinase production, extracellular protease production, and the biosynthesis of the siderophore ornibactin (29, 32-34). Proteomic analysis of B. cenocepacia cepI mutant revealed that 55 of 985 examined proteins are differentially expressed in the quorum-sensing mutant and the wild type (48). Animal and nematode infection models have demonstrated a role for the cepIR quorum-sensing system in B. cenocepacia virulence (30, 55).
In epidemic strains of B. cenocepacia that possess the B. cenocepacia pathogenicity island (cci), CepR is required for the expression of an additional quorum-sensing system, cciIR (5, 39). The predominant AHL produced by the AHL synthase, CciI, is HHL with minor amounts of OHL (39). The cciI and cciR genes are cotranscribed, and CciR negatively regulates the expression of the cciIR operon. CciR is involved in the negative regulation of cepI as well as in the regulation of extracellular protease production and swarming motility (39).
B. vietnamiensis strains possess an additional quorum-sensing system, bviIR. PCR amplification and Southern hybridization analysis revealed that B. vietnamiensis is the only BCC species to contain the bviIR system (10, 36). In addition to OHL and HHL, B. vietnamiensis strains produce N-decanoyl-homoserine lactone (DHL), N-dodecanoyl-homoserine lactone, and N-(3oxodecanoyl)-homoserine lactone (10, 11, 44). Mutations constructed in bviI and bviR of B. vietnamiensis strain G4 (bviIG4 and bviRG4, respectively) indicated that BviI is responsible for the synthesis of all AHLs produced by G4 in that the bviI mutant did not produce detectable levels of any AHL except minor amounts of OHL (10). Although B. vietnamiensis possesses the genes for two quorum-sensing systems, its AHL production has been shown to be strain dependent with regard to type and quantity of AHL produced (11, 26, 72).
Few phenotypes are known to be regulated by the bviIR system. One study suggested that a B. vietnamiensis G4 transposon mutant with decreased AHL production showed reduced antibiotic production, although this antibiotic has yet to be characterized (44). In the same study, it was determined that the degradation of toluene and thus the expression of toluene ortho-monooxygenase is not regulated by quorum sensing (44). There is also evidence that the bviIR system is not involved in siderophore production (10).
The objectives of this study were to further characterize the bviIR and cepIR quorum-sensing systems of B. vietnamiensis G4, as well as the regulatory relationship between the two quorum-sensing systems. In this study we also investigate the basis for the variations in AHL production in clinical and environmental B. vietnamiensis strains at a molecular level.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
|
View this table: [in a new window] |
TABLE 2. Oligonucleotide primers used in this study
|
Analysis of quorum-sensing genes in B. vietnamiensis strains. The presence of the bviIR genes in seven B. vietnamiensis strains was determined by PCR with primers RTbviIF and RTbviIR for bviI and RTbviRF and RTbviRR for bviR. The bviIR loci from strains FC466, FC441, C2822, and G4 were cloned by PCR amplification of a 2.6-kb fragment from genomic DNA using the bviIKOR and bviRKOR primers. The nucleotide sequence for the G4 bviIR locus was confirmed with the incomplete B. vietnamiensis G4 sequencing project (http://www.jgi.doe.gov/), which contained only 1.2 kb of the G4 bviIR locus. Since the complete cepIG4 sequence was not available through the JGI sequencing project, the cepI gene was amplified on an 826-bp fragment with the G4cepIF and G4cepIR primers and sequenced. The presence of the open reading frame 7349 and 7350 LuxRI homologue genes in seven B. vietnamiensis strains was determined by PCR with primers IN7349F and IN7349R and IN7350F and IN7350R, respectively.
Construction of cepI and cepR mutants. To construct a cepI::cat mutant of B. vietnamiensis G4, a 2.2-kb PstI fragment from pRM6.8 containing cepI was blunt ended and cloned into the EcoRV site of pCR2.1Topo (Invitrogen). A SmaI fragment from p35S-Cm (14) harboring a Cm resistance cassette was inserted into the MluI site of cepI, and the resulting fragment was subcloned into pEX18Tc (27) with BamHI and XbaI, resulting in pRM2X2-Cm, which was transferred into G4 by conjugation. Transconjugants were plated onto Pseudomonas isolation agar (Difco) plates with Cm to select for single-crossover events. Attempts to identify a cepI::cat mutant by screening Cm-resistant colonies for Tc sensitivity and loss of the plasmid were unsuccessful. Attempts were made to construct the cepI mutant with pEXCEPI (32) and other vectors with various amounts of flanking DNA and different resistance cassettes. None were successful; therefore, the G4 cepI mutant (G4cepI) is a merodiploid. The mutation was confirmed by PCR with the internal cepI primers UnicepIF and UnicepIR.
To construct a cepR::cat mutant of G4, a 2.4-kb fragment containing cepR was PCR amplified using the G4cepRKOF and G4cepRKOR primers and cloned into pEX18Tc (27), resulting in pRM2X1. The cepR open reading frame was disrupted at the PstI site by the Cm resistance cassette from p34S-Cm (14), resulting in pRM2X1-Cm. Attempts to construct a cepR::cat mutant were carried out as outlined above, again resulting in the merodiploid, G4cepR. The mutation was confirmed by PCR with the primers cepRF and cepRR. The cepR mutant of PC259 (PC259cepR) was constructed using the allelic-exchange vector pEXCEPR (33). The mutation was confirmed by PCR with the cepRF and cepRR primers and Southern hybridization using a 650-bp cepR probe PCR amplified with the same primers.
Construction of cepI and cepR insertion mutants of G4. The cepI and cepR genes in B. vietnamiensis G4 were inactivated by insertion of pGSV3 (15). A 426-bp internal cepI fragment was PCR amplified using the UnicepIF and UnicepRR primers, and the resulting fragment was cloned into pCR2.1Topo. An EcoRI fragment containing the cepI fragment was cloned into pGSV3 (15) to construct pRMSVI. The cepR insertional activation construct pRMSVR was constructed in a similar manner following PCR amplification of a 647-bp cepR fragment with the cepRF and cepRR primers. The pRMSVR and pRMSVI constructs were mobilized into G4 by conjugation using pRK2013 (21). Transconjugants were plated onto Pseudomonas isolation agar (Difco) plates containing Gm. Insertions were confirmed by PCR with the G4cepIF and G4cepIR primers for the cepI mutant (G4cepIGSV) and with the G4cepRKOF and G4cepRKOR primers for the cepR mutant (G4cepRGSV).
Construction of luxCDABE transcriptional fusions. Promoter regions were predicted in silico using SoftBerry BPROM. Promoter fragments were amplified by PCR and cloned upstream of the luxCDABE operon in the XhoI/BamHI promoter cloning site of pMS402 (18) as follows. The cepI-luxCDABE transcriptional fusion plasmid pRM463 was constructed by amplifying a 266-bp promoter fragment using the primers R2Cla3RE and ExcepI (33). The cepR-luxCDABE transcriptional fusion plasmid pRM462 was constructed by amplifying a 227-bp cepR promoter fragment with the cepRProF and cepRProR primers. The bviR-luxCDABE transcriptional fusion plasmid pRM464 was constructed by amplifying a 695-bp promoter fragment with the bviRUF and bviRUR primers. The bviI-luxCDABE transcriptional fusion plasmid pRM465 was constructed by amplifying a 983-bp fragment with the bviIproX and bviIproB primers. The bviI-luxCDABE transcriptional fusions pRM455, pRM475, pRM485, pRM495, and pRM415 were constructed using the respective genomic DNA (PC259, FC466, FC441, FC369T, and DBO1) as a template.
The cepI-luxCDABE transcriptional fusion plasmid pRM453 was constructed by amplifying a 769-bp promoter fragment from PC259 DNA with the INcepI and ExcepI primers (33) The cepR-luxCDABE transcriptional fusion plasmid pRM452 was constructed as previously described (39), using PC259 genomic DNA as the template.
Luminescence assays. Overnight cultures were subcultured to an initial optical density at 600 nm (OD600) of 0.02 in 20 ml medium. At selected times, 100-µl aliquots were removed and the luminescence in counts per second and turbidity at an OD600 or OD620 were measured using a Wallac Victor2 multilabel counter (Perkin Elmer Life Sciences, Woodbridge, Ontario, Canada) or a MicroBeta TriLux microplate scintillation and luminescence counter (Perkin Elmer Life Sciences). The samples were read in black, clear-bottom, 96-well microtiter plates (Corning, Inc., Corning, NY). The level of promoter expression is reported as the ratio of luminescence to turbidity or relative luminescence. Luminescence assays for screening for gene expression in a 96-well plate format were performed as described above, with overnight cultures being subcultured (1/100) into 150 µl of medium.
RT-PCR. Overnight cultures were subcultured (1/100) into 20 ml medium and grown for 24 h. Total RNA was isolated from approximately 1 x 109 cells with the RiboPure-Bacteria RNA isolation kit (Ambion, Austin, TX). RNA was treated with amplification-grade DNase I (Invitrogen) before use. Reverse transcription (RT)-PCR was performed using a Titan one-tube RT-PCR kit (Roche) according to the manufacturer's instructions. For each reaction, 50 ng of RNA was used. cDNA was synthesized by RT at 50°C for 40 min. Denaturation was performed for 2 min at 96°C, followed by 35 cycles of PCR as suggested by the manufacturer. A final elongation step at 68°C for 7 min was conducted.
The sigA gene encodes the principal sigma factor (8) and was used as a control gene. A homologue of B. cepacia sigA was identified in the B. vietnamiensis G4 sequencing project (http://www.jgi.doe.gov/. B. vietnamiensis G4 SigA is 89.93% identical to SigA of B. cepacia (accession no. AAD03549) (8).
Three primer sets were designed to internally amplify bviI, bviR, and sigA to yield 297-bp, 297-bp, and 347-bp products, respectively. The annealing temperatures and primers used are as follows: for bviI, 58°C with RTbviIF and RTbviIR; for bviR, 64°C with RTbviRF and RTbviRR; and for sigA, 62°C with RTsigAF and RTsigAR. To ensure that there was no DNA contamination in the RNA samples, PCR was performed on the RNA samples using the RTsigAF and RTsigAR primers with Platinum Taq polymerase (Invitrogen). RTbviRF and RTbviRR primers yielded an approximately 745-bp nonspecific contaminating band (data not shown). This band was sequenced, and a BLAST (3) search indicated that the fragment has homology to B. vietnamiensis LMG10929T 23S rRNA and is not related to bviR.
TLC-AHL bioassays. AHLs were extracted from 40 ml of culture supernatants with equal volumes of acidified ethyl acetate as described elsewhere (33). Thin-layer chromatography and AHL extraction (TLC-AHL) bioassays were performed as described previously using Agrobacterium tumefaciens A136(pCF218)(pCF372) as a reporter strain (33). This reporter strain is able to identify AHLs with 3-oxo, 3-hydroxy, and 3-unsubstituted side chains ranging from 6 to 12 carbons in length (53). Synthetic HHL, OHL, and DHL (Sigma-Aldrich) were used as reference standards.
Phenotypic characterization. Siderophore activity present in the culture supernatant fluid was measured by chrome azurol S assays (32, 52). Biofilm formation was determined by staining the cellular matter with crystal violet as described by Tomlin et al. (59), except that biofilms were formed on the polystyrene pegs of a 96-peg replica plate lid inserted in a 96-well plate containing the culture (Nalge Nunc International, Rochester, NY). Swarming motility was evaluated using semisolid agar (0.5%) motility assays as previously described (34). Virulence studies with the alfalfa infection model were performed as previously described (6, 7), with 40 sprouts per group and incubation of the sprouts at 30°C for 7 days. The API 20NE (bioMerieux, St. Laurent, Quebec, Canada) were used for testing basic biochemical attributes as per the instructions of the manufacturer. The ability to fix atmospheric nitrogen was tested by determining growth in the nitrogen-free medium BAz (20) after 48 h of growth at 30°C under anaerobic conditions. Antibiotic production was determined by disk diffusion as previously described (44) on lawns of Micrococcus luteus ATCC 9341.
Statistics. Statistical analyses, including unpaired t tests and analyses of variance, were performed with INSTAT software (GraphPad Software, San Diego, CA). A P value of <0.05 was considered significant.
Nucleotide sequence accession numbers. The G4, FC466, FC441, and C2822 bviIR sequences were deposited into the NCBI database with the respective accession nos. EF032807, EF032808, EF032809, and EF032810. In addition, the cepI gene sequence was deposited into the NCBI database with the accession no. EF212890.
|
|
|---|
![]() View larger version (16K): [in a new window] |
FIG. 1. Transcriptional analysis of B. vietnamiensis quorum-sensing genes. All values are means ± standard deviations of the results of triplicate assays. , G4; , G4 bviR mutant (RMT-14); , G4cepR (PC259); , PC259; , PC259cepR. (A) Effect of BviR on bviI expression (bviI-luxCDABE, pRM465). (B) Effect of CepR on cepI expression (cepI-luxCDABE, pRM463). (C) Effect of CepR on cepR expression (cepR-luxCDABE, pRM462). (D) Effect of CepR on cepR expression (cepR-luxCDABE, pRM452). The expression of pRM452 was significantly greater in PC259cepR from 3 to 12 h (P < 0.05, t test). (E) Effect of CepR on cepI expression (cepI-luxCDABE, pRM453). (F) Effect of CepR on bviI expression (bviI-luxCDABE, pRM465). CPS, counts per second.
|
To determine whether there is a regulatory relationship between the cepIR and bviIR systems, comparative transcriptional analysis of cepI and cepR-luxCDABE transcriptional fusions in G4 and the G4 bviR mutant as well as analysis of the expression of bviI and bviR-luxCDABE in G4 and G4cepR were performed. The levels of expression of cepR and cepI were similar in G4 and the G4 bviR mutant (data not shown), indicating that BviR is not involved in the regulation of the cepIR system. The levels of expression of bviR were also similar between the parent and the cepR mutant (data not shown); however, the expression of bviI in the G4 cepR mutant was reduced to almost background levels (Fig. 1F), indicating that CepR positively regulates bviI in G4. To determine whether CepR positively regulates bviI in PC259, RT-PCR was performed to amplify bviI and bviR from PC259 and the PC259 cepR mutant total RNA (Fig. 2). RT-PCR was employed since bviI expression was not detected in PC259 using the bviI- luxCDABE fusion plasmid pRM455 (Table 3). There was a smaller amount of the bviR product in the PC259 cepR mutant than in PC259 (Fig. 2, compare lanes 3a and 3b) and no detectable bviI product in the PC259 cepR mutant (Fig. 2, lane 2b), indicating that CepR positively regulates the bviIR system in PC259. The sigA gene was used as a control, and there was no observable difference in expression between PC259 and the PC259 cepR mutant (Fig. 2, compare lanes 4a and 4b).
![]() View larger version (13K): [in a new window] |
FIG. 2. Effect of CepR on bviIR expression in PC259 by RT-PCR. Products were electrophoresed on a 1.0% gel. Lane 1, ladder; lanes 2a to 2c, product amplified by RTbviIF and RTbviIR; lanes 3a to 3c, product amplified by RTbviRF and RTbviRR; lanes 4a to 4c, product amplified by RTsigAF and RTsigAR; lane 5, ladder. Lanes a, PC259 RNA; lanes b, PC259cepR RNA; lanes c, no-template control.
|
|
View this table: [in a new window] |
TABLE 3. Summary of AHL production, bviIR gene presence, and bviIR expression in clinical and environmental B. vietnamiensis strainsi
|
![]() View larger version (29K): [in a new window] |
FIG. 3. AHL production profiles of the quorum-sensing mutants using TLC-AHL bioassays with the A. tumefaciens(pCF218)(pCF372) reporter strain. (A) AHL production profile of G4 bviI and bviR mutants. Lane 1, G4(pUCP28T); lane 2, G4 bviR(pUCP28T); lane 3, G4 bviR(pRM612) containing the bviR gene; lane 4, G4 bviI(pUCP28T); lane 5, G4 bviI(pRM611) containing the bviI gene; lane 6, synthetic standards. (B) AHL production profiles of cepIR mutants. Lane 1, G4; lane 2, G4cepR; lane 3, G4cepI; lane 4, PC259; lane 5, PC259cepR; lane 6, synthetic standards. (C) AHL production profiles of the G4 cepI and G4 cepR insertion mutants. Lane 1, G4; lane 2, G4cepIGSV; lane 3, G4cepRGSV; lane 4, synthetic standards.
|
The discrepancies between the G4 cepR merodiploid and the PC259 cepR haploid mutant, with regard to the regulation of cepIR and AHL production, prompted a second mutant construction strategy for G4. Mutant construction has proven successful in Burkholderia mallei and Burkholderia thailandensis by insertion of pGSV3 (15, 42). G4 cepI and cepR mutants were constructed with this approach and were designated G4cepIGSV and G4cepRGSV, respectively. PCR analysis indicated that the mutant cultures had a mixture of wild-type and mutated cepI or cepR genes (data not shown), indicating that the mutation was not stable. The presence of bacteria with wild-type genes decreased with increasing Gm concentrations (data not shown), although there were always revertants in the population. The AHL production profiles of G4cepIGSV and G4cepRGSV were unaffected (Fig. 3C, compare lanes 2 and 3 with lane 1); therefore, these mutants were not studied further.
Assays, including siderophore biosynthesis, biofilm formation, antibiotic production, nitrogen fixation, and swarming motility assays (12, 29, 32-34, 44), were performed to determine whether the bviIR quorum-sensing system is involved in phenotypes known to be quorum-sensing regulated. Extracellular protease production and expression of the AHL-dependent gene aidA were not investigated, since B. vietnamiensis does not produce proteases and G4 does not contain aidA (25, 26, 72). G4 did not exhibit swarming motility, was not virulent in the alfalfa model of infection, and was unable to grow on nitrogen-free media. Previously, G4 AHL production was correlated with antibacterial activity that inhibited the growth of M. luteus (44); however, we found that M. luteus was not sensitive to G4-secreted products. The levels of siderophore biosynthesis in the G4 bviI and bviR mutants were indistinguishable from that in wild-type G4 (data not shown). The bviI and bviR mutants exhibited marginally less biofilm formation; however, this decrease was not restored when bviI and bviR were added in trans (data not shown). The bviI and bviR mutants did not exhibit a phenotype distinguishable from that of the wild type in any of the API 20 NE biochemical tests (data not shown).
Analysis of differences in AHL production in clinical and environmental strains of B. vietnamiensis. AHL production in the BCC is strain dependent with respect to quantity and type of AHL produced (11, 26, 72). Since the regulation of the quorum-sensing systems appeared to be strain dependent, further investigation into the differences in AHL production by B. vietnamiensis strains was pursued. The AHL production profiles of seven B. vietnamiensis strains were determined by TLC-AHL bioassays (Table 3). Only one of four clinical strains but all three environmental strains produced DHL, suggesting that the bviIR genes may be less expressed in clinical strains than in environmental strains, since OHL and HHL could be produced by CepI in these strains.
The presence of the bviI and bviR genes in the seven B. vietnamiensis strains was confirmed by PCR analysis with primers that amplified DNA fragments internal to bviI and bviR (Table 3). To determine whether bviI and bviR are expressed in the clinical strains that do not produce DHL, RT-PCR was performed (Table 3). There was a decrease in amplification of the bviR RT-PCR products and no detectable bviI RT-PCR products from the non-DHL-producing strains, indicating that the bviI and bviR genes are poorly expressed in these three strains. The bviI RT-PCR data were confirmed for the majority of strains by transcriptional analysis of bviI-luxCDABE transcriptional fusions (Table 3). The only discrepancy was that the expression of bviI in PC259 was almost at background levels, whereas a bviI RT-PCR product was obviously amplified.
Given that BviR is implicated in the positive regulation of bviI and that the expression of bviR was lower in the three non-DHL-producing clinical strains, heterologous expression of bviRG4 was performed to determine whether the absence of bviI expression in these strains was due to a lack of induction by BviR (Fig. 4A). The presence of bviRG4 in trans restored DHL production in each of the strains (Fig. 4A, lanes 3, 5, and 7), suggesting that the absence of bviI expression in the non-DHL-producing strains is due to a hindered induction of bviI by BviR.
![]() View larger version (49K): [in a new window] |
FIG. 4. Heterologous expression of bviRG4 and cepRG4 in non-DHL-producing clinical strains using TLC-AHL bioassays with the A. tumefaciens(pCF218)(pCF372) reporter strain. (A) AHL production profile of non-DHL-producing strains complemented with bviRG4 in trans. Lane 1, FC466(pRM284); lane 2, FC466(pUCP28T); lane 3, FC411(pRM284); lane 4, FC441(pUCP28T); lane 5, C2822(pRM284); lane 6, C2822(pUCP28T); lane 7, synthetic standards. (B) AHL production profile of non-DHL-producing strains with cepRG4 in trans. Lane 1, FC466(pRM282); lane 2, FC466(pUCP28T); lane 3, FC411(pRM282); lane 4, FC441(pUCP28T); lane 5, C2822(pRM282); lane 6, C2822(pUCP28T); lane 7, synthetic standards.
|
To determine whether the absence of bviI expression in the non-DHL-producing strains is due to sequence differences upstream of bviI, expression of bviIG4-luxCDABE in PC259, FC466, FC441, and C2822 and expression of bviIPC259-luxCDABE in FC369T, DBO1, and G4 were examined (Table 3). There was expression of the bviIPC259-luxCDABE fusion in FC369T, DBO1, and G4, but there was no detectable bviIG4-luxCDABE fusion expression in FC466, FC441, and C2822, indicating that the lack of bviI expression in these three clinical strains is not due to mutations in the bviI promoter region.
It is possible that the lack of DHL production in these three clinical strains may be due to CepR not inducing bviI expression, since CepR positively regulates bviI in both G4 and PC259. Heterologous expression of cepRG4 in FC466, FC441, and C2822 was performed to determine whether CepR is able to induce bviI (Fig. 4B). The presence of cepRG4 increased the production of HHL and OHL in FC466 (Fig. 4B, compare lanes 1 and 2), but it did not restore DHL production in FC466, FC441, or C2822 (Fig. 4B, lanes 1, 3, and 5), indicating that the lack of DHL is not due to a lack of CepR functioning as a positive regulator of bviI in these strains.
Additional LuxI and LuxR homologues were identified in silico by a BLAST search (3) of the incomplete draft G4 genome sequence (http://www.jgi.doe.gov/) with Vibrio fischeri LuxI (accession no. 1403259B) (17), LuxR of V. fischeri (accession no. 1403259A) (17), B. vietnamiensis PC259 CepI (accession no. AAK70355) (36), and B. vietnamiensis PC259 CepR (accession no. AAK70352) (36). There are at least three LuxI homologues and five LuxR homologues present in the G4 genome draft sequence. There are three sets of AHL synthase/transcriptional regulator pairs, including cepIR, bviIR, and an additional system designated open reading frames 7349 and 7350 (http://www.jgi.doe.gov/). There are two LuxR homologues that do not have a proximal AHL synthase and are designated open reading frames 6095 and 3039 (http://genome.ornl.gov/microbial/bcep_1808/).
To determine whether open reading frame 7350 encodes a functional AHL synthase, the 7350 open reading frame was cloned and expressed in E. coli. There were no AHLs detected in the culture supernatant of E. coli(pRM292), containing 7350, when the A. tumefaciens TLC-AHL bioassay was performed under the conditions used to visualize AHLs produced by both cepI and bviI (data not shown). The presence of the 7349/7350 luxIR homologues in other B. vietnamiensis strains was determined by PCR with primers that amplified DNA fragments internal to 7349 and 7350. All of the strains except for PC259 and C2822 contained these genes (Table 3).
|
|
|---|
The AHL production profiles of the quorum-sensing mutants confirmed the transcriptional-analysis experiments. The G4 cepI mutant AHL production profile exhibits less HHL and OHL than the wild type, presumably due to the lack of synthesis of these AHLs by CepI; however, the G4 cepI mutant did not produce detectable levels of DHL. With less AHL present in the environment of the cepI mutant, there would be less of the active AHL-bound form of CepR, leading to a decrease in bviI expression and the synthesis of DHL.
It is curious that all of the environmental isolates tested produced DHL but that all of the clinical isolates examined either did not produce DHL or had less bviI expression than G4. The ability of BCC strains to produce AHLs has been extensively surveyed, and a clear correlation between the quantity or the type of AHL produced and the origin of the strain has not been demonstrated (11, 26, 72). These three studies employed different methodologies but agree with the current study of the AHLs produced by all strains except FC441, for which one study reported DHL production (72). All 3 environmental isolates collectively assayed in four independent studies produced DHL, whereas 4 out of the 10 clinical isolates either did not produce DHL or did not produce DHL as their predominant AHL (11, 26, 72), suggesting less DHL production in B. vietnamiensis clinical strains.
It has been suggested that differences between environmental strains and those which cause infections may occur at the level of the regulation of genes rather than in their presence or absence (45). Heterologous expression of bviR from G4 in the clinical non-DHL-producing strains restored DHL production, implicating inefficient induction of bviI by BviR as the reason for the absence of DHL production in these three strains. Transcriptional analysis of the G4 bviI promoter in the non-DHL-producing strains and of the PC259 bviI promoter in the DHL-producing strains determined that the lack of bviI expression is not due to mutations in the bviI promoter region, suggesting that an unknown upstream regulatory element influences the expression of bviI. Heterologous expression of cepR from G4 in the clinical non-DHL-producing strains did not restore DHL production; therefore, CepR is not the affected upstream regulatory element. The distribution of the luxR homologue 7349 is inconsistent with that of the non-DHL-producing strains, and 7349 is not likely the involved upstream regulator. Like B. vietnamiensis G4, B. pseudomallei and B. thailandensis possess three complete AHL-mediated quorum-sensing systems and two additional luxR homologues (61, 63). B. mallei possesses two luxI and four luxR homologues (62). The regulatory networks of these systems have yet to be characterized, but each gene may play a role in the coordinate expression of quorum-controlled genes.
Environmental conditions influence the expression of quorum-sensing networks (50) and could be a factor in the expression of bviI and the production of DHL in the clinical non-DHL-producing strains. Expression of bviI and DHL production were greater when cultures were grown at 30°C than at 37°C (data not shown). Efforts were made to identify culture conditions for bviI expression in the non-DHL-producing strains, yet none were found. However, the possibility that bviI can be expressed in these strains under specific environmental conditions should be acknowledged.
This study has resulted in further characterization of the B. vietnamiensis quorum-sensing regulatory network, yet little is known about what genes are regulated by these systems. Since the G4 bviIR mutants retain the ability to produce HHL and OHL, it is believed that the cepIR system and potentially the 7349/7350 system are still functional in these mutants and compensate for mutations in bviIR, making it difficult to detect phenotypic differences in the mutants. It might be possible to detect quorum-sensing-regulated phenotypes by constructing double or triple mutants; however, the construction of such mutants of B. vietnamiensis proves difficult, as this species is less amenable to genetic manipulation than other BCC species. There is a possibility of analyzing the effect of the absence of AHLs in B. vietnamiensis strains by employing a quorum-quenching approach, as suggested by Wopperer et al. (72). With this approach, Wopperer et al. (72) determined that aidA, a cepIR-regulated gene of unknown function that is involved in nematode virulence (28), is also regulated by quorum sensing in B. vietnamiensis strains. The quorum-quenching approach, however, does not make it possible to distinguish which quorum-sensing system is involved in the regulation of aidA in B. vietnamiensis.
Quorum-sensing systems in B. cepacia and B. cenocepacia regulate many physiological processes (19, 65). Proteomic (48) and transcriptional (58) analyses of quorum-sensing mutants of B. cenocepacia have been successful in identifying numerous quorum-sensing-regulated genes. With further development of molecular tools for B. vietnamiensis, including a complete genome sequence, the role of quorum sensing in regulating environmentally beneficial phenotypes as well as pathogenic traits may be elucidated.
We thank T. Louie for providing M. luteus.
Published ahead of print on 2 February 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»